Friday 6 November 2026
Export IDXX’s income statement to Excel — free account
IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +9.86%
- EPS
- +17.3%
- Free cash flow
- +17.6%
- Total debt
- −28.6%
Quarter to September 2026, against a year earlier
669.01
29.54
−4.23%
Follow IDXX
Alert me
IDEXX Laboratories, Inc. (IDXX) revenue by segment, product and region
Where the money comes from and where it goes
| CAG | 3,953 | 91.86% |
|---|---|---|
| Water segment revenue | 201 | 4.67% |
| LPD | 132 | 3.06% |
| Gross margin | 61.80% | |
| Operating margin | 31.60% | |
| Pre-tax margin | 30.77% |
Revenue by product or service $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | 2,539 59.00% | 2,248 57.68% | 2,090 57.09% | 1,929 57.28% | 1,875 58.32% | 1,587 58.63% | 1,423 59.13% | 1,323 59.76% | 1,176 59.73% | 1,071 60.32% |
| Service revenue | 1,764 41.00% | 1,649 42.32% | 1,571 42.91% | 1,439 42.72% | 1,340 41.68% | 1,120 41.37% | 984 40.87% | 891 40.24% | 793 40.27% | 704 39.68% |
| Revenue | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | 2,213 | 1,969 | 1,775 |
Gross profit by product or service $m, and margin
Revenue by segment $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAG | 3,953 91.86% | 3,574 91.70% | 3,352 91.57% | 3,059 90.84% | 2,890 89.88% | 2,386 88.14% | 2,119 88.05% | 1,935 87.45% | 1,703 86.51% | 1,523 85.76% | 1,356 84.67% | 1,223 82.32% | 1,140 82.81% | 1,072 82.90% | 1,000 82.03% | 906 82.08% | 843 81.74% |
| Water segment revenue | 201 4.67% | 185 4.75% | 168 4.59% | 156 4.62% | 147 4.56% | 129 4.75% | 133 5.52% | 125 5.66% | 114 5.81% | 104 5.83% | 97 6.05% | 95 6.38% | 88 6.39% | 85 6.55% | 82 6.74% | 77 6.93% | 73 7.10% |
| LPD | 132 3.06% | 122 3.13% | 122 3.32% | 123 3.64% | 136 4.23% | 146 5.39% | 133 5.51% | 131 5.90% | 128 6.52% | 126 7.12% | 127 7.94% | 141 9.50% | 124 8.98% | 111 8.61% | 114 9.32% | 81 7.36% | 77 7.48% |
| Other segment revenue | — | — | — | — | 43 1.34% | 46 1.72% | 22 0.92% | 22 1.00% | 23 1.16% | 23 1.28% | 22 1.35% | 27 1.81% | 25 1.82% | 25 1.94% | 23 1.91% | 40 3.63% | 38 3.67% |
| Cag Lpd Segment Transition | — | — | — | — | — | — | — | — | — | — | — | 14 0.93% | 10 0.72% | — | — | — | — |
| Other, not broken out | — | — | 19 0.51% | 30 0.90% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Eliminations | — | — | — | — | — | — | — | — | — | — | — | (14) (0.93%) | (10) (0.72%) | — | — | — | — |
| Revenue | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | 2,213 | 1,969 | 1,775 | 1,602 | 1,486 | 1,377 | 1,293 | 1,219 | 1,103 | 1,032 |
Operating income by segment $m, and margin
Operating figures as reported in each quarter’s results release or filing
| Figure | Quarter | Latest | A year before | Change |
|---|---|---|---|---|
| Days sales outstanding | Q3 FY2026 | 46.70 | 46.50 | +0.43% |
| Global premium instrument installed base growth | Q3 FY2026 | 11.0% | — | — |
| IDEXX inVue Dx placements | Q3 FY2026 | 1.9K | 1.7K | +11.76% |
| Inventory turns | Q3 FY2026 | 1.5× | 1.5× | 0.00% |